Literature DB >> 19360468

Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Da-Rong Pu1, Jun R Chiong, Qi-chang Zhou.   

Abstract

N-terminal fragment of pro B-type natriuretic peptide (NT-proBNP) has emerged as an important adjunct in the management of heart failure (HF) and other cardiovascular diseases. NT-proBNP is a 76-amino acid peptide created during cleavage of the precursor molecule, Pro B-type natriuretic peptide (ProBNP). NT-proBNP is of significant diagnostic value in patients presenting with possible HF and is an important prognostic factor in this condition and other cardiovascular diseases. Ongoing research supports the potential value of this biomarker in non-cardiovascular disease. This review will describe clinical applications of NT-proBNP in HF and a broad range of other conditions.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19360468     DOI： 10.1007/s10741-009-9142-1

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN： 1382-4147            Impact factor:   4.214


  118 in total

1.  The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.

Authors:  Hyo Jin Choi; Young Kee Shin; Hyun Joo Lee; Joo Young Kee; Dong Woo Shin; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Clin Rheumatol       Date:  2007-09-25       Impact factor: 2.980

2.  Preoperative, postoperative and 1-year follow-up N-terminal pro-B-type natriuretic peptide levels in severe chronic aortic regurgitation: correlations with echocardiographic findings.

Authors:  Alessandro Della Corte; Gemma Salerno; Emilio Chiosi; Diana Iarussi; Giuseppe Santarpino; Maurizio Miraglia; Silvio Naviglio; Marisa De Feo
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-03-19

3.  Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Authors:  Anna Fijalkowska; Marcin Kurzyna; Adam Torbicki; Grzegorz Szewczyk; Michal Florczyk; Piotr Pruszczyk; Monika Szturmowicz
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.

Authors:  Alex Zaphiriou; Stephen Robb; Tarita Murray-Thomas; Gustavo Mendez; Kevin Fox; Theresa McDonagh; Suzanna M C Hardman; Henry J Dargie; Martin R Cowie
Journal:  Eur J Heart Fail       Date:  2005-06       Impact factor: 15.534

5.  Raised plasma aldosterone and natriuretic peptides in atrial fibrillation.

Authors:  Ulrik Dixen; Lasse Ravn; Christian Soeby-Rasmussen; Anders Wallin Paulsen; Jan Parner; Erik Frandsen; Gorm B Jensen
Journal:  Cardiology       Date:  2006-09-12       Impact factor: 1.869

6.  N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Christian W Hamm; Veselin Mitrovic; Nicte-Ha Lantelme; Harvey D White
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

7.  Value of NT-proBNP determinations in the follow-up of heart transplantation.

Authors:  A Cuppoletti; E Roig; F Pérez-Villa; J L Marin; J Orús; I Vallejos; A Rivera; C Botta
Journal:  Transplant Proc       Date:  2005-11       Impact factor: 1.066

8.  B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.

Authors:  Yoshitaka Iwanaga; Isao Nishi; Shinichi Furuichi; Teruo Noguchi; Kazuhiro Sase; Yasuki Kihara; Yoichi Goto; Hiroshi Nonogi
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

9.  Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.

Authors:  Onder Celik; Ibrahim Sahin; Nilufer Celik; Seyma Hascalik; Lezzan Keskin; Hamdi Ozcan; Ahmet Uckan; Feridun Kosar
Journal:  Hum Reprod       Date:  2007-09-12       Impact factor: 6.918

10.  Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure.

Authors:  Fabian Knebel; Stephan Eddicks; Ingolf Schimke; Michael Bierbaum; Sebastian Schattke; Mark Beling; Vanessa Raab; Gert Baumann; Adrian C Borges
Journal:  Cardiovasc Ultrasound       Date:  2008-09-08       Impact factor: 2.062
View more
  4 in total

1.  Can NT-proBNP be used as a criterion for heart failure hospitalization in emergency room?

Authors:  Tuba Cimilli Ozturk; Erol Unluer; Arzu Denizbasi; Ozlem Guneysel; Ozge Onur
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

2.  NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.

Authors:  Amal Zidan; Laila M Sherief; Amera El-sheikh; Safaa H Saleh; Doaa A Shahbah; Naglaa M Kamal; Hanan S Sherbiny; Heba Ahmad
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

3.  N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.

Authors:  Shihui Fu; Jie Jiao; Yi Guo; Bing Zhu; Leiming Luo
Journal:  BMC Geriatr       Date:  2019-02-28       Impact factor: 3.921

4.  Pro-BDNF Contributes to Hypoxia/Reoxygenation Injury in Myocardial Microvascular Endothelial Cells: Roles of Receptors p75NTR and Sortilin and Activation of JNK and Caspase 3.

Authors:  Fei Yu; Yuezhu Liu; Junmei Xu
Journal:  Oxid Med Cell Longev       Date:  2018-06-26       Impact factor: 6.543
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.